Senti Biosciences Holdings, Inc.

US$0.16As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SNTIHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (69.38%)
Div yield —
ROE (466.46%)
Biotechnology
Beta (5Y) 2.33
PE TTM —
TSR TTM (92.12%)
Mkt cap US$4.983M
ROIC (91.57%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.176
9.86%
(97.65%)
Hold 11|10|12|6|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
32.41%
22.45%
17.85%
20.76%
Revenue$M
0.234
0.234
0.240
0.238
4.67%
2.44%
5.40%
5.11%
Peers (US$4.983M)
Cap (US$)
PE
5.040M
—
4.878M
—
5.049M
6.626x
Capital
TTM
5Y
10Y
Leveragex
0.510
(0.414)
(0.366)
EBIT/Intx
4.471
0.296
0.256
Own earn%
338.22
45.12
77.90
Sh yield%
44.09
21.79
24.43
Owners
Insiders/Inst%
12.64
74.66
Short interest%
4.53
SBC / revenue%
3.35
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
8–11
$1 testx
—
Incr. ROIC%
4